WP
TENX icon

Woodline Partners’s Tenax Therapeutics TENX Stock Holding History

Woodline Partners’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73M Buy
531,254
+207,343
+64% +$2.65M 0.02% 593
2026
Q1 		$5.18M Buy
323,911
+180,430
+126% +$2.44M 0.02% 657
2025
Q4 		$1.75M Buy
143,481
+55,270
+63% +$481K 0.01% 785
2025
Q3 		$671K Buy
+88,211
New +$539K ﹤0.01% 823

Other funds holding TENX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Woodline Partners's TENX Position: Q2 2026 in Review

Woodline Partners increased its Tenax Therapeutics (TENX) stake by 64% in Q2 2026, buying an estimated $2.65M and bringing the position to 531,254 shares worth $7.73M. The position accounts for 0.02% of the portfolio, ranked #593.

Woodline Partners first reported a position in TENX in Q3 2025 and has held it in 4 quarters since. 111 funds tracked by Wall St. Rank hold TENX as of Q2 2026.

  • Woodline Partners held 531,254 shares of Tenax Therapeutics worth $7.73M as of Q2 2026.
  • Woodline Partners bought 207,343 Tenax Therapeutics shares in Q2 2026, an estimated $2.65M.
  • Tenax Therapeutics made up 0.02% of Woodline Partners's portfolio in Q2 2026, its #593 holding.
  • Woodline Partners first reported a position in Tenax Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 111 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.